447 related articles for article (PubMed ID: 32677984)
1. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
[TBL] [Abstract][Full Text] [Related]
2. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.
Pan J; Fang S; Tian H; Zhou C; Zhao X; Tian H; He J; Shen W; Meng X; Jin X; Gong Z
Mol Cancer; 2020 Jan; 19(1):9. PubMed ID: 31941509
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA RP11-283G6.5 confines breast cancer development through modulating miR-188-3p/TMED3/Wnt/β-catenin signalling.
Pei J; Zhang S; Yang X; Han C; Pan Y; Li J; Wang Z; Sun C; Zhang J
RNA Biol; 2021 Oct; 18(sup1):287-302. PubMed ID: 34130584
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
Zhan Y; Chen Z; He S; Gong Y; He A; Li Y; Zhang L; Zhang X; Fang D; Li X; Zhou L
Mol Cancer; 2020 Feb; 19(1):25. PubMed ID: 32019566
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B
J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993
[TBL] [Abstract][Full Text] [Related]
6. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
[TBL] [Abstract][Full Text] [Related]
7. lncRNA SNHG11 Promotes Gastric Cancer Progression by Activating the Wnt/β-Catenin Pathway and Oncogenic Autophagy.
Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
Mol Ther; 2021 Mar; 29(3):1258-1278. PubMed ID: 33068778
[TBL] [Abstract][Full Text] [Related]
8. REST-repressed lncRNA NPPA-AS1 regulates cervical cancer progression by modulating miR-302e/DKK1/Wnt/β-catenin signaling pathway.
Luan Y; Xie B; Wei W
J Cell Biochem; 2021 Jan; 122(1):16-28. PubMed ID: 32965043
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.
Wang W; Hu W; Wang Y; An Y; Song L; Shang P; Yue Z
Mol Cancer; 2020 Jan; 19(1):18. PubMed ID: 31996265
[TBL] [Abstract][Full Text] [Related]
10. CASC9 Facilitates Cell Proliferation in Bladder Cancer by Regulating CBX2 Expression.
Huo W; Tan D; Chen Q
Nephron; 2020; 144(8):388-399. PubMed ID: 32570259
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
[TBL] [Abstract][Full Text] [Related]
12. LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis.
Rui X; Wang L; Pan H; Gu T; Shao S; Leng J
J Cell Mol Med; 2019 Feb; 23(2):865-876. PubMed ID: 30394665
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
[TBL] [Abstract][Full Text] [Related]
14. LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1.
Han T; Gao M; Wang X; Li W; Zhuo J; Qu Z; Chen Y
Exp Mol Pathol; 2021 Jun; 120():104639. PubMed ID: 33865827
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA.
Zhan Y; Chen Z; Li Y; He A; He S; Gong Y; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):273. PubMed ID: 30419948
[TBL] [Abstract][Full Text] [Related]
16. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
Tang Y; Yang P; Zhu Y; Su Y
Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
[TBL] [Abstract][Full Text] [Related]
19. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CASC9 promotes the progression and development of gastric cancer via regulating miR-370/EGFR axis.
Li C; Zhang J; Zhou Y; Li B
Dig Liver Dis; 2021 Apr; 53(4):509-516. PubMed ID: 33478874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
